Paces Ferry Wealth Advisors LLC boosted its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 5.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,116 shares of the company’s stock after acquiring an additional 110 shares during the quarter. Paces Ferry Wealth Advisors LLC’s holdings in Procter & Gamble were worth $315,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC increased its stake in shares of Procter & Gamble by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 46,243,572 shares of the company’s stock worth $6,997,559,000 after purchasing an additional 323,292 shares during the last quarter. Morgan Stanley boosted its holdings in Procter & Gamble by 12.6% in the 4th quarter. Morgan Stanley now owns 44,320,700 shares of the company’s stock valued at $6,717,246,000 after purchasing an additional 4,959,527 shares during the period. Moneta Group Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 96,526.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 38,535,557 shares of the company’s stock worth $5,840,449,000 after acquiring an additional 38,495,676 shares during the last quarter. Norges Bank bought a new stake in Procter & Gamble in the fourth quarter worth $3,752,321,000. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Procter & Gamble by 11.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,150,848 shares of the company’s stock valued at $2,599,383,000 after acquiring an additional 1,722,462 shares during the period. Institutional investors own 64.65% of the company’s stock.
Procter & Gamble Stock Down 2.1 %
PG stock opened at $148.80 on Monday. The firm has a 50 day moving average of $149.97 and a 200 day moving average of $147.34. The stock has a market capitalization of $350.72 billion, a PE ratio of 25.92, a price-to-earnings-growth ratio of 3.83 and a beta of 0.42. The company has a quick ratio of 0.39, a current ratio of 0.59 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 52 week low of $122.18 and a 52 week high of $158.11.
Procter & Gamble Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, May 15th. Shareholders of record on Friday, April 21st were paid a dividend of $0.9407 per share. This represents a $3.76 annualized dividend and a yield of 2.53%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.91. The ex-dividend date of this dividend was Thursday, April 20th. Procter & Gamble’s payout ratio is presently 65.51%.
Insider Buying and Selling at Procter & Gamble
In related news, insider Susan Street Whaley sold 4,852 shares of the business’s stock in a transaction on Wednesday, April 26th. The shares were sold at an average price of $155.47, for a total value of $754,340.44. Following the completion of the transaction, the insider now directly owns 7,977 shares in the company, valued at approximately $1,240,184.19. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Susan Street Whaley sold 4,852 shares of the company’s stock in a transaction on Wednesday, April 26th. The shares were sold at an average price of $155.47, for a total transaction of $754,340.44. Following the completion of the sale, the insider now owns 7,977 shares of the company’s stock, valued at $1,240,184.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Andre Schulten sold 25,244 shares of the company’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $155.27, for a total transaction of $3,919,635.88. Following the sale, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at approximately $4,210,611.86. The disclosure for this sale can be found here. In the last ninety days, insiders sold 95,093 shares of company stock worth $14,821,930. Company insiders own 0.26% of the company’s stock.
Analyst Ratings Changes
Several research analysts have recently issued reports on the stock. Barclays upped their target price on shares of Procter & Gamble from $160.00 to $167.00 in a research note on Wednesday, April 26th. Morgan Stanley raised their target price on shares of Procter & Gamble from $160.00 to $174.00 and gave the company an “overweight” rating in a research note on Monday, April 24th. Truist Financial lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price objective for the company from $165.00 to $155.00 in a research report on Thursday, May 18th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Procter & Gamble from $160.00 to $170.00 and gave the company a “buy” rating in a report on Monday, April 24th. Finally, Jefferies Financial Group raised their target price on shares of Procter & Gamble from $171.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, April 24th. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $161.50.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Read More
- Five stocks we like better than Procter & Gamble
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
- Who Wins And Who Loses With China’s Metal Restrictions
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
